Drug intelligence / Profile preview

levomefolate + methylcobalamin + pyridoxal 5-phosphate

Development stage
Unknown
Lead developer
Solis Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Pyrifol-M is an oral combination vitamin product developed by Solis Pharma, containing the biologically active forms of vitamins B9 (levomefolate), B12 (methylcobalamin), and B6 (pyridoxal 5-phosphate). Unlike synthetic folic acid or pyridoxine, these coenzymated forms do not require extensive metabolic conversion, making them highly effective for individuals with enzymatic deficiencies. The formulation is primarily indicated for the management of nutritional deficiencies and hyperhomocysteinemia, and it is frequently used to support neurological health in conditions such as diabetic peripheral neuropathy. Levomefolate facilitates DNA synthesis and the remethylation of homocysteine to methionine, while methylcobalamin serves as an essential cofactor for methionine synthase. Pyridoxal 5-phosphate acts as a coenzyme for numerous enzymatic reactions, including the transsulfuration pathway that further regulates homocysteine levels.

Brand names
Pyrifol-M
Other names
Methyl Folate 1mg, Methylcobalamin 1500mcg & Pyridoxal 5 Phosphate 5mg Tablets
02

Targets

MTR (Methionine synthase)CBS (Cystathionine beta-synthase)

Beyond the preview

Go deeper on levomefolate + methylcobalamin + pyridoxal 5-phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on levomefolate + methylcobalamin + pyridoxal 5-phosphate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call